Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-123312

Chairman & CEO bought 150 shares at $7.45 ($1,118)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-30 Purchase : show line 1 in the form +150 $7.45 $1,118 3,015,459 D
Open-market purchases · 150 sh · avg $7.45 · $1,118
Loading xslF345X03/tm2231703-1_4seq1.xml…